Vimarsana
Biggest News Aggregation in the World

Page 17 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

Satellos Bioscience Inc.: Satellos Bioscience Announces 2022 Year End Financial Results and Operational Highlights - Vimarsana News

Satellos Bioscience Inc.: Satellos Bioscience Announces 2022 Year End Financial Results and Operational Highlights

Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics

Arterra Bioscience, profit rises in 2022; revenue also up - Vimarsana News

Arterra Bioscience, profit rises in 2022; revenue also up

The board of directors of Arterra Bioscience Spa reviewed and approved the draft financial statements for the year ending December 31, 2022, reporting a profit of EUR1.4 million from EUR1.1 million in... | March 30, 2023

iTolerance, Inc. CEO to Present at the Bio LaunchPad Seminar at Georgia Tech's Institute for Bioengineering and Bioscience - Vimarsana News

iTolerance, Inc. CEO to Present at the Bio LaunchPad Seminar at Georgia Tech's Institute for Bioengineering and Bioscience

Livestream presentation to be held on Thursday, March 30, 2023 at 11:00 AM ETMIAMI, FL / ACCESSWIRE / March 29, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine

Satellos Bioscience Inc.: Satellos Bioscience Announces Closing of Previously Announced Non-Brokered Offering of $2.385 Million of Unsecured Non-Convertible Debentures - Vimarsana News

Satellos Bioscience Inc.: Satellos Bioscience Announces Closing of Previously Announced Non-Brokered Offering of $2.385 Million of Unsecured Non-Convertible Debentures

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics

Satellos Bioscience Inc.: Satellos Bioscience to Present at Annual MDA Clinical and Scientific Conference and Insights in Research Investor Summit - Vimarsana News

Satellos Bioscience Inc.: Satellos Bioscience to Present at Annual MDA Clinical and Scientific Conference and Insights in Research Investor Summit

Ryan Mitchell, PhD and Director of Business Development at Satellos to highlight SAT-3153 and Satellos' novel muscle regeneration technology in two forums at this year's MDA Conference and Summit Toronto